5442932025-07-012025-09-305442932025-09-305442932025-03-315442932025-04-012025-09-305442932025-07-012025-09-30in-capmkt:OtherExpenses1Member5442932025-07-012025-09-30in-capmkt:OtherExpenses2Member5442932025-07-012025-09-30in-capmkt:OtherExpenses3Member5442932025-07-012025-09-30in-capmkt:OtherExpenses4Member5442932025-07-012025-09-30in-capmkt:OtherExpenses5Member5442932025-07-012025-09-30in-capmkt:OtherExpenses6Member5442932025-07-012025-09-30in-capmkt:OtherExpenses7Member5442932025-07-012025-09-30in-capmkt:OtherExpenses8Member5442932025-07-012025-09-30in-capmkt:OtherExpenses9Member5442932025-07-012025-09-30in-capmkt:OtherExpenses10Member5442932025-04-012025-09-30in-capmkt:OtherExpenses1Member5442932025-04-012025-09-30in-capmkt:OtherExpenses2Member5442932025-04-012025-09-30in-capmkt:OtherExpenses3Member5442932025-04-012025-09-30in-capmkt:OtherExpenses4Member5442932025-04-012025-09-30in-capmkt:OtherExpenses5Member5442932025-04-012025-09-30in-capmkt:OtherExpenses6Member5442932025-04-012025-09-30in-capmkt:OtherExpenses7Member5442932025-04-012025-09-30in-capmkt:OtherExpenses8Member5442932025-04-012025-09-30in-capmkt:OtherExpenses9Member5442932025-04-012025-09-30in-capmkt:OtherExpenses10Member5442932025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15442932025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25442932025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15442932025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25442932025-07-012025-09-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544293SURAKSHANOTLISTEDINE877V01027SURAKSHA DIAGNOSTIC LIMITEDMain BoardEquity2025-04-012026-03-312025-11-102025-11-03INRLakhsQuarterlySecond quarterSingle segmentDIAGNOSTIC2025-11-1014:30:002025-11-1016:15:00trueCash Flow IndirectDeclaration of unmodified opinion2025-07-012025-09-30UnauditedConsolidated7872900008514000795804000890080000013391600027758000101432000323221000675335000120469000012046900030983000120900032192000088277000000088277000-420008823500089864000-158700089822000-158700010416200021.731.73001.731.730001. The unaudited consolidated financial results for the quarter and six months ended 30 September 2025 of Suraksha Diagnostic Limited and its subsidiary Holding company and subsidiaries together referred to as the group have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard notified under Section 133 of the Companies Act 2013 as amended read with relevant rules thereunder and other accounting principles generally accepted in India and in accordance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 as amended. <BR> 2. These unaudited consolidated financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their respective meeting held on 10 November 2025. The statutory auditor have carried out limited review on these financial results and have issued an unmodified conclusion. <BR> 3. The Group is primarily engaged in the business of diagnostic centres for carrying out various pathology and radiology services and as such there are no separate reportable segments as per Ind AS 108 Operating Segments. <BR> 4. The Holding Company has completed the acquisition of Fetomat Wellness Private Limited on 08 April 2025 by acquisition of 373423 equity shares of equity shares of Rs 10 each representing 63 percent of the total equity share capital of Fetomat resulting in Fetomat becoming a subsidiary of the Company. As per Ind AS 103 Business Combinations, the transaction has been accounted for and the difference between the consideration paid on acquisition and the fair value of net identifiable assets acquired attributed to the Holding Company has been accounted for as Goodwill as on the date of acquisition. <BR> 5. These unaudited consolidated financial results are also available on the Holding Companys website www.surakshanet.com and on the stock exchange websites at www.bseindia.com and www.nseinda.com. <BR> 6. Previous periods or years figures have been regrouped or reclassified wherever necessary to conform to current periods or years classification. <BR> 2025-04-012025-09-30UnauditedConsolidated151315300017571000153072400017651300000261663000548070001962560005963290001285568000245156000024515600059765000536300065128000018002800000001800280001904000181932000183838000-3810000185742000-381000010416200023.533.53003.533.53000Impairment loss2045000Advertisement15886000Professional fees paid to doctors142719000Power and fuel23769000Repairs and maintenance25475000Information technology expenses11378000Security and housekeeping charges19566000Commission to collection centers14773000Sample testing and collection charges13459000Other Expenses54151000Impairment loss-6859000Advertisement23402000Professional fees paid to doctors270120000Power and fuel47644000Repairs and maintenance46420000Information technology expenses24743000Security and housekeeping charges36782000Commission to collection centers26389000Sample testing and collection charges23139000Other Expenses10454900016698110001881000038801000105560400090530000015050700015050700012567400030682600008446100001362760002107200041487000001009800058231600067442000734219000380247900010416200021997520002303914000-96900002294224000762600010131240001020750000938900060329000109046800019346000124600001514100001638700002044400003876560002827200013270005320004177870001508255000380247900054807000-3857000100190000-4088500000168640000257700000-70310000196257000-685900017860000-3026300000014612000577500000001174000020894500045410100000087170000036693100003271000000000091700023461500000000000000000000016332000032023000-218053000000000000332760001149350000206300000-150274000-13960000-13960002246800021072000Remeasurement gain/(loss) of net defined benefit plan-56000Income tax effect on above14000-42000Remeasurement gain/(loss) of net defined benefit plan2544000Income tax effect on above-640000190400000-420001904000UnauditedtrueMSKA & Associatestrue2027-07-31